# Progress Note 07 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Zora Neale Hurston (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML040-SYN-TD
- Date: 1958-10-19
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lorraine Abernathy-Osei, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Seven-month review: blood pressure, heart failure and screening results. **S**

## History of present illness

Ms. Hurston returns five weeks after her annual wellness visit. She is substitute teaching two or three days a week and finishing a chapter of her new book. She walks to the bus without stopping and has had no lightheadedness, chest pain or swelling. Her home blood pressure average is 122/74. Her drug plan with Extra Help now supplies all five medicines in 90-day fills. Her screening results: the stool test (FIT) was negative, the mammogram was normal, the hepatitis C antibody was negative, and the bone density scan showed osteopenia (lowest T-score -1.6 at the femoral neck) with a ten-year risk of hip fracture below the level at which medicine is advised. The optometrist found mild hypertensive changes in the retinas without bleeding or swelling. She would like her zoster and Tdap vaccines today. **S**

| Element | Detail |
|---|---|
| Home blood pressure | Average 122/74 mmHg |
| Function | NYHA class I to II; teaching two or three days a week |
| Screening | FIT, mammogram and hepatitis C negative; osteopenia, below the treatment threshold |
| Eyes | Mild hypertensive retinopathy; no hemorrhage or swelling |
| KCCQ-12 | 78 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain, palpitations or edema |
| Neurological | Negative | No headache, lightheadedness, weakness, numbness, speech or vision change |
| Musculoskeletal | Negative | No falls |

3 systems reviewed. **S**

## Current medications

- Amlodipine 5 mg oral tablet, one tablet every morning **S**
- Chlorthalidone 25 mg oral tablet, one-half tablet (12.5 mg) every morning **S**
- Dapagliflozin 10 mg oral tablet, one tablet daily; pause on days of vomiting, diarrhea or not eating or drinking **S**
- Atorvastatin 20 mg oral tablet, one tablet daily **S**
- Spironolactone 25 mg oral tablet, one-half tablet (12.5 mg) daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 124/74 mmHg; pulse 70 bpm; respirations 16/min; temperature 36.5 °C; oxygen saturation 98% on room air; weight 81.2 kg; BMI 29.8 kg/m². All vital signs are synthetic.

Sodium: 139 mmol/L; Potassium: 4.3 mmol/L; Creatinine: 0.92 mg/dL; eGFR (CKD-EPI 1953): 68 mL/min/1.73 m²; Glucose: 96 mg/dL; Magnesium: 2 mg/dL; KCCQ-12 overall summary: 78. All results are synthetic.

## Change since baseline

- Sodium: 140 mmol/L at baseline, 139 mmol/L at this visit **S**
- Potassium: 3.9 mmol/L at baseline, 4.3 mmol/L at this visit **S**
- Creatinine: 0.88 mg/dL at baseline, 0.92 mg/dL at this visit **S**
- eGFR (CKD-EPI 1953): 72 mL/min/1.73 m² at baseline, 68 mL/min/1.73 m² at this visit **S**
- Glucose: 96 mg/dL at baseline, 96 mg/dL at this visit **S**
- Magnesium: 2 mg/dL at baseline, 2 mg/dL at this visit **S**

## Immunizations given today

- Recombinant zoster vaccine, dose 1 of 2 **S**
- Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 124/74, pulse 70; weight 81.2 kg |
| Neck | Jugular venous pressure not raised |
| Cardiovascular | Regular rhythm; soft S4 |
| Respiratory | Clear |
| Extremities | No edema |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Hypertensive heart disease** (I11.0). At goal for four months, 124/74 in the clinic and 122/74 at home. Controlling blood pressure is her best protection against stroke, the complication she is most at risk of. **S**
   - No change.
   - Metabolic panel every three to six months; lipid panel, urine albumin and hemoglobin A1c at one year.
   - BE FAST and call 911.
2. **Heart failure with preserved ejection fraction** (I50.32). Stable, NYHA class I to II; KCCQ-12 78, from 54. **S**
   - Continue current medicines; cardiology review at six months as planned.
3. **Osteopenia on bone density scan**. Below the threshold for medicine. **S**
   - Calcium from food, vitamin D, walking and balance exercises; repeat scan in several years.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure in the clinic (seated, average of two readings, large cuff) | Every visit | Completed today | 124/74 mmHg |
| Examination | Out-of-office blood pressure (ambulatory at diagnosis; home readings when treatment changes) | At diagnosis and with each treatment change | Completed today | Home average 122/74 mmHg |
| Examination | Weight, volume status (jugular venous pressure, edema, lungs) and NYHA class | Every visit | Completed today | 81.2 kg; jugular venous pressure not raised; no edema; NYHA I to II |
| Laboratory | Metabolic panel (sodium, potassium, creatinine and eGFR) and magnesium | Every three to six months when stable | Completed today | Sodium 139, potassium 4.3, creatinine 0.92 mg/dL (eGFR 68), magnesium 2.0 |
| Survey | KCCQ-12 heart failure health status | At diagnosis, then every three to six months | Completed today | 78 |
| Laboratory | Lipid panel | Four to twelve weeks after starting a statin; then yearly | Up to date | LDL 76 mg/dL at the eight-week review; next at one year |
| Laboratory | Urine albumin-to-creatinine ratio | Yearly | Up to date | 22 mg/g at intake; due at one year |
| Laboratory | Hemoglobin A1c | Yearly | Up to date | 5.6% at intake; due at one year |
| Imaging | ECG and echocardiogram | At diagnosis; repeat only with unexplained clinical change | Not indicated | Stable; no unexplained change |
| Survey | Depression screen (PHQ-2, then PHQ-9 if positive) | Yearly | Up to date | PHQ-2 0 at the wellness visit |
| Examination | Eye examination for hypertensive retinopathy | Yearly | Up to date | Dilated optometry examination since the wellness visit: mild hypertensive retinopathy without hemorrhage or swelling |
| Self-management | Self-care: daily weights, less salt, sick-day rules and the BE FAST stroke signs | Every visit | Completed today | Weighs daily; heat plan through the summer; BE FAST reviewed |
| Medication safety | Medicine costs and coverage (generics, 90-day fills, patient assistance, Extra Help, Medicare Savings Program) | Every visit | Completed today | All five medicines through her drug plan with Extra Help, in 90-day fills |
| Self-management | Food access | Every visit | Completed today | Food lasts the month |

## Goal progress

- Blood pressure below 130/80 mmHg in the clinic and at home within six months. Outcome by 1958-06-01: 126/76 in the clinic; home average 124/74. **S**
- Breathlessness only on heavy exertion and a KCCQ-12 score at least 15 points higher within six months. Outcome by 1958-10-19: KCCQ-12 54 to 78; NYHA class I to II; ankles no longer swell. **S**
- Every medicine affordable: generic 90-day fills, patient assistance until drug coverage begins, Extra Help and the Medicare Savings Program. Outcome by 1958-06-01: Extra Help and the Medicare Savings Program approved; enrolled in a drug plan; dapagliflozin by patient assistance until then. **S**
- Enough food through the month. Outcome by 1958-06-01: SNAP approved and the food pantry at her church; food lasts the month. **S**
- Know the BE FAST signs of stroke and call 911 at once if any appear. Outcome by 1958-04-06: She teaches back the signs and keeps the card by the telephone. **S**

## Guideline basis

- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology (Circulation 2025;152(11):e114-e218)
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (2022), American Heart Association, American College of Cardiology, and Heart Failure Society of America (Circulation 2022;145(18):e895-e1032)
- CMID: Clinical Monitoring Intelligence Database, hypertension and heart failure monographs (2026), Aether Forge
- Signs and Symptoms of Stroke (2026), Centers for Disease Control and Prevention
- Osteoporosis to Prevent Fractures: Screening (2025), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Zoster dose 1 and Tdap given today; second zoster dose in two to six months. Review in three months with a metabolic panel. Cardiology review at six months from consultation. Call 911 for any BE FAST sign. **S**

